GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Innovent Biologics 1801.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

86.45

+0.12%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Innovent Biologics

Our reporting

Next results

31 Mar 2027

Due on 31 Mar 2027. Analysts expect earnings of 1.31 a share on revenue of CN¥12.52bn.

Past results

Reported against what analysts expected

25 Aug 202626 Mar 202626 Aug 202526 Mar 202528 Aug 202420 Mar 2024
Earnings per share0.81-0.010.560.19-0.26-0.62
Forecast0.540.130.20-0.24-0.27-0.55
RevenueCN¥9.94bnCN¥7.94bnCN¥6.51bnCN¥5.82bnCN¥4.24bnCN¥3.88bn
ForecastCN¥10.28bnCN¥7.67bnCN¥6.16bnCN¥4.95bnCN¥4.06bnCN¥8.22bn

Key events

  1. 31 Oct 2018Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.